Company intelligence / Profile preview

National Pharma Investment

Muscat, Muscat, Oman

Ownership: Private
Development stage: Other

Overview

National Pharmaceutical Investment (NPIC) is an Omani-based investment holding company focused on the healthcare and pharmaceutical sectors. The company primarily serves as a strategic vehicle for investing in pharmaceutical manufacturing and distribution infrastructure within the Sultanate of Oman and the broader GCC region. Its most notable asset is a significant majority stake in National Pharmaceutical Industries (NPI), the first pharmaceutical manufacturing plant in Oman. NPIC plays a key role in Oman's 'Vision 2040' by promoting local drug production and reducing reliance on imported medicines.

Industry: Investors

Beyond the preview

Go deeper on National Pharma Investment.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on National Pharma Investment.

Explore the full profile